DCAF4L1
gene geneOn this page
Summary
DCAF4L1 (DDB1 and CUL4 associated factor 4 like 1, HGNC:27723) is a protein-coding gene on chromosome 4p13, encoding DDB1- and CUL4-associated factor 4-like protein 1 (Q3SXM0).
Located in cytoplasm.
Source: NCBI Gene 285429 — RefSeq curated summary.
At a glance
- GWAS associations: 4
- Clinical variants (ClinVar): 31 total
- MANE Select transcript:
NM_001029955
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:27723 |
| Approved symbol | DCAF4L1 |
| Name | DDB1 and CUL4 associated factor 4 like 1 |
| Location | 4p13 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000182308 |
| Ensembl biotype | protein_coding |
| Entrez | 285429 |
Gene structure
Transcript identifiers
Ensembl transcripts: 1 — 1 protein_coding
ENST00000333141
RefSeq mRNA: 1 — MANE Select: NM_001029955
NM_001029955
CCDS: CCDS33978
Canonical transcript exons
ENST00000333141 — 1 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001308497 | 41981756 | 41986465 |
Expression profiles
Bgee: expression breadth ubiquitous, 140 present calls, max score 97.05.
FANTOM5 (CAGE): breadth tissue_specific, TPM avg 0.0651 / max 51.5388, expressed in 3 samples.
FANTOM5 promoters (1 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 47508 | 0.0651 | 3 |
Top tissues by expression
234 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 97.05 | gold quality |
| oocyte | CL:0000023 | 96.06 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 94.51 | gold quality |
| secondary oocyte | CL:0000655 | 94.05 | gold quality |
| testis | UBERON:0000473 | 86.86 | gold quality |
| sperm | CL:0000019 | 86.82 | gold quality |
| right testis | UBERON:0004534 | 86.34 | gold quality |
| left testis | UBERON:0004533 | 85.10 | gold quality |
| buccal mucosa cell | CL:0002336 | 84.64 | gold quality |
| gastrocnemius | UBERON:0001388 | 63.77 | gold quality |
| muscle of leg | UBERON:0001383 | 62.30 | gold quality |
| adult organism | UBERON:0007023 | 62.21 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 60.15 | gold quality |
| oviduct epithelium | UBERON:0004804 | 60.02 | silver quality |
| granulocyte | CL:0000094 | 58.76 | gold quality |
| islet of Langerhans | UBERON:0000006 | 56.30 | gold quality |
| lower lobe of lung | UBERON:0008949 | 55.69 | silver quality |
| heart left ventricle | UBERON:0002084 | 54.33 | gold quality |
| leukocyte | CL:0000738 | 54.02 | gold quality |
| monocyte | CL:0000576 | 53.90 | gold quality |
| cardiac ventricle | UBERON:0002082 | 53.84 | gold quality |
| adenohypophysis | UBERON:0002196 | 53.17 | gold quality |
| pituitary gland | UBERON:0000007 | 52.60 | gold quality |
| bone marrow cell | CL:0002092 | 52.50 | gold quality |
| spleen | UBERON:0002106 | 52.31 | gold quality |
| mucosa of stomach | UBERON:0001199 | 51.89 | gold quality |
| right coronary artery | UBERON:0001625 | 51.89 | gold quality |
| blood | UBERON:0000178 | 51.88 | gold quality |
| heart | UBERON:0000948 | 51.40 | gold quality |
| metanephros cortex | UBERON:0010533 | 51.14 | gold quality |
Single-cell (SCXA)
Detected in 3 experiment(s), a significant marker in 2.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-GEOD-134144 | yes | 30.02 |
| E-ANND-3 | yes | 3.84 |
| E-CURD-10 | no | 281.90 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
94 targeting DCAF4L1, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5011-5P | 100.00 | 83.46 | 5820 |
| HSA-MIR-190A-3P | 100.00 | 80.35 | 5520 |
| HSA-MIR-8485 | 100.00 | 77.57 | 4731 |
| HSA-MIR-3613-3P | 100.00 | 76.36 | 7965 |
| HSA-MIR-6758-5P | 100.00 | 66.21 | 1470 |
| HSA-MIR-3646 | 100.00 | 73.56 | 5283 |
| HSA-MIR-6856-5P | 100.00 | 65.47 | 1298 |
| HSA-MIR-371B-5P | 99.99 | 75.34 | 4759 |
| HSA-MIR-4282 | 99.99 | 75.36 | 6408 |
| HSA-MIR-4482-3P | 99.98 | 72.50 | 3147 |
| HSA-MIR-373-5P | 99.98 | 75.36 | 4753 |
| HSA-MIR-616-5P | 99.98 | 75.58 | 4775 |
| HSA-MIR-302C-5P | 99.97 | 72.56 | 3642 |
| HSA-MIR-548AT-5P | 99.96 | 70.83 | 2666 |
| HSA-LET-7C-3P | 99.95 | 73.42 | 2862 |
| HSA-MIR-3910 | 99.95 | 71.13 | 2227 |
| HSA-MIR-9983-3P | 99.94 | 71.48 | 3631 |
| HSA-MIR-144-3P | 99.94 | 73.98 | 2698 |
| HSA-MIR-3143 | 99.93 | 71.96 | 3104 |
| HSA-MIR-552-5P | 99.93 | 68.56 | 1583 |
| HSA-MIR-6835-3P | 99.93 | 70.49 | 2904 |
| HSA-MIR-1297 | 99.91 | 73.41 | 3162 |
| HSA-MIR-7-1-3P | 99.91 | 71.53 | 4384 |
| HSA-MIR-7-2-3P | 99.91 | 71.40 | 4394 |
| HSA-MIR-4493 | 99.90 | 66.48 | 977 |
| HSA-MIR-95-5P | 99.89 | 72.17 | 3973 |
| HSA-MIR-129-5P | 99.88 | 70.26 | 3273 |
| HSA-MIR-7845-5P | 99.88 | 64.88 | 771 |
| HSA-MIR-5582-3P | 99.86 | 72.48 | 4221 |
| HSA-MIR-3941 | 99.86 | 70.54 | 2735 |
Cross-species orthologs
0 orthologs
Paralogs (26): PAFAH1B1 (ENSG00000007168), SNRNP40 (ENSG00000060688), WDR62 (ENSG00000075702), WDR7 (ENSG00000091157), TBL2 (ENSG00000106638), PAK1IP1 (ENSG00000111845), WDR75 (ENSG00000115368), DCAF4 (ENSG00000119599), DAW1 (ENSG00000123977), TEP1 (ENSG00000129566), AHI1 (ENSG00000135541), WDR38 (ENSG00000136918), MAPKBP1 (ENSG00000137802), POC1B (ENSG00000139323), NEDD1 (ENSG00000139350), COP1 (ENSG00000143207), WDR17 (ENSG00000150627), WDR43 (ENSG00000163811), POC1A (ENSG00000164087), WDR88 (ENSG00000166359), WDR81 (ENSG00000167716), DCAF4L2 (ENSG00000176566), WDR27 (ENSG00000184465), NWD1 (ENSG00000188039), WDR5 (ENSG00000196363), WDR5B (ENSG00000196981)
Protein
Protein identifiers
DDB1- and CUL4-associated factor 4-like protein 1 — Q3SXM0 (reviewed: Q3SXM0)
Alternative names: WD repeat-containing protein 21B
All UniProt accessions (1): Q3SXM0
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Cytoplasm.
RefSeq proteins (1): NP_001025126* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001680 | WD40_rpt | Repeat |
| IPR015943 | WD40/YVTN_repeat-like_dom_sf | Homologous_superfamily |
| IPR036322 | WD40_repeat_dom_sf | Homologous_superfamily |
| IPR052254 | CUL4-DDB1_E3_ligase_receptor | Family |
Pfam: PF23761
UniProt features (5 total): repeat 2, sequence conflict 2, chain 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q3SXM0-F1 | 85.13 | 0.47 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 26 (showing top):
GSE18804_SPLEEN_MACROPHAGE_VS_BRAIN_TUMORAL_MACROPHAGE_UP, GOCC_TRANSFERASE_COMPLEX, GOCC_CUL4_RING_E3_UBIQUITIN_LIGASE_COMPLEX, GOCC_CULLIN_RING_UBIQUITIN_LIGASE_COMPLEX, GOCC_UBIQUITIN_LIGASE_COMPLEX, MIR9983_3P, MIR4482_3P, MIR302B_5P, MIR302D_5P, GSE11864_UNTREATED_VS_CSF1_PAM3CYS_IN_MAC_DN, MIR4709_5P, MIR502_5P, BLANCO_MELO_MERS_COV_INFECTION_MCR5_CELLS_UP, BLANCO_MELO_COVID19_SARS_COV_2_LOW_MOI_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP, BLANCO_MELO_COVID19_SARS_COV_2_INFECTION_A594_ACE2_EXPRESSING_CELLS_UP
GO Biological Process (0):
GO Molecular Function (1): protein binding (GO:0005515)
GO Cellular Component (2): cytoplasm (GO:0005737), Cul4-RING E3 ubiquitin ligase complex (GO:0080008)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| binding | 1 |
| intracellular anatomical structure | 1 |
| cellular anatomical structure | 1 |
| cullin-RING ubiquitin ligase complex | 1 |
Protein interactions and networks
STRING
288 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| DCAF4L1 | TMEM33 | P57088 | 431 |
| DCAF4L1 | GTF3C3 | Q9Y5Q9 | 407 |
| DCAF4L1 | AP5S1 | Q9NUS5 | 400 |
| DCAF4L1 | PAGE2B | Q5JRK9 | 397 |
| DCAF4L1 | UBALD1 | Q8TB05 | 393 |
| DCAF4L1 | ZSCAN23 | Q3MJ62 | 370 |
| DCAF4L1 | ZNF814 | B7Z6K7 | 370 |
| DCAF4L1 | DDB1 | Q16531 | 351 |
| DCAF4L1 | CHADL | Q6NUI6 | 349 |
| DCAF4L1 | AP5Z1 | O43299 | 339 |
| DCAF4L1 | PODNL1 | Q6PEZ8 | 325 |
| DCAF4L1 | RHOXF1 | Q8NHV9 | 324 |
| DCAF4L1 | C11orf42 | Q8N5U0 | 324 |
| DCAF4L1 | AP4S1 | Q9Y587 | 322 |
| DCAF4L1 | AP3S2 | P59780 | 321 |
IntAct
12 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| COPS6 | RHOBTB1 | psi-mi:“MI:0914”(association) | 0.730 |
| DCAF4L1 | CUL4A | psi-mi:“MI:0914”(association) | 0.730 |
| CUL4A | COPS2 | psi-mi:“MI:0914”(association) | 0.640 |
| DCAF4L1 | SNRPA1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| CUL4A | HAX1 | psi-mi:“MI:0914”(association) | 0.350 |
| COPS5 | FBLL1 | psi-mi:“MI:0914”(association) | 0.350 |
| COPS6 | DDX3X | psi-mi:“MI:0914”(association) | 0.350 |
| DCAF4L1 | PFDN6 | psi-mi:“MI:0914”(association) | 0.350 |
| DCAF4L1 | VWA8 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (28): CUL4A (Affinity Capture-MS), CUL4A (Affinity Capture-MS), CUL4B (Affinity Capture-MS), DCAF4L1 (PCA), DCAF4L1 (Proximity Label-MS), DCAF4L1 (Affinity Capture-MS), DCAF4L1 (Affinity Capture-MS), CUL4A (Affinity Capture-MS), CUL4B (Affinity Capture-MS), LONP1 (Affinity Capture-MS), PDRG1 (Affinity Capture-MS), CCT6A (Affinity Capture-MS), CCT7 (Affinity Capture-MS), PFDN6 (Affinity Capture-MS), CCT5 (Affinity Capture-MS)
ESM2 similar proteins: A0A140LI67, A0A1W2PR48, A0JP70, D3YYM4, F1LW30, O13034, O15040, O70173, Q15345, Q3SXM0, Q3UDP0, Q3UJB9, Q3ULW6, Q3V129, Q3ZAV8, Q58DC2, Q5F479, Q5JV73, Q5M9H0, Q5M9H1, Q5R6T6, Q5R9H2, Q68DX3, Q6IRN0, Q6NV72, Q6P2E9, Q6P4K6, Q6PCD5, Q6ZPG2, Q6ZW76, Q7TNH6, Q80TQ5, Q8BLD6, Q8C008, Q8C5V5, Q8CBW4, Q8CIK8, Q8IWE5, Q8JZL1, Q8K1C9
Diamond homologs: Q3SXM0, Q58DC2, Q8NA75, Q8WV16, Q8RXA7
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
31 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 31 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
184 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 4:41983026:G:GT | donor_gain | 0.9800 |
| 4:41983030:T:G | donor_gain | 0.9600 |
| 4:41983109:GGG:G | donor_gain | 0.9300 |
| 4:41983110:GGG:G | donor_gain | 0.9300 |
| 4:41983030:TTAA:T | donor_gain | 0.8900 |
| 4:41982873:G:GT | donor_gain | 0.8600 |
| 4:41982993:T:TA | donor_gain | 0.8400 |
| 4:41983117:GTGT:G | donor_gain | 0.8100 |
| 4:41983118:TGTT:T | donor_gain | 0.8100 |
| 4:41982281:GTTCT:G | donor_gain | 0.7900 |
| 4:41982282:TTCTT:T | donor_gain | 0.7900 |
| 4:41982957:G:GT | donor_gain | 0.7900 |
| 4:41982994:G:GA | donor_gain | 0.7900 |
| 4:41982921:G:GT | donor_gain | 0.7800 |
| 4:41983026:G:T | donor_gain | 0.7800 |
| 4:41982172:TG:T | donor_gain | 0.7700 |
| 4:41982668:A:T | donor_gain | 0.7700 |
| 4:41982921:G:T | donor_gain | 0.7500 |
| 4:41982765:G:GT | donor_gain | 0.7400 |
| 4:41982980:C:G | donor_gain | 0.7000 |
| 4:41982954:C:T | donor_gain | 0.6800 |
| 4:41982167:G:GT | donor_gain | 0.6400 |
| 4:41982173:GA:G | donor_gain | 0.6200 |
| 4:41982174:AA:A | donor_gain | 0.6200 |
| 4:41982168:A:T | donor_gain | 0.6000 |
| 4:41983110:GG:G | donor_gain | 0.5800 |
| 4:41983111:GG:G | donor_gain | 0.5800 |
| 4:41983119:GTTA:G | donor_gain | 0.5800 |
| 4:41983027:A:T | donor_gain | 0.5700 |
| 4:41983107:CAGGG:C | donor_loss | 0.5700 |
AlphaMissense
2581 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 4:41982393:A:C | S201R | 0.994 |
| 4:41982395:T:A | S201R | 0.994 |
| 4:41982395:T:G | S201R | 0.994 |
| 4:41982813:T:A | W341R | 0.990 |
| 4:41982813:T:C | W341R | 0.990 |
| 4:41982360:T:A | W190R | 0.986 |
| 4:41982360:T:C | W190R | 0.986 |
| 4:41982681:T:A | W297R | 0.986 |
| 4:41982681:T:C | W297R | 0.986 |
| 4:41982783:G:C | A331P | 0.986 |
| 4:41982815:G:C | W341C | 0.984 |
| 4:41982815:G:T | W341C | 0.984 |
| 4:41982486:T:C | F232L | 0.983 |
| 4:41982488:T:A | F232L | 0.983 |
| 4:41982488:T:G | F232L | 0.983 |
| 4:41982795:G:C | D335H | 0.980 |
| 4:41982809:A:C | R339S | 0.979 |
| 4:41982809:A:T | R339S | 0.979 |
| 4:41982683:G:C | W297C | 0.977 |
| 4:41982683:G:T | W297C | 0.977 |
| 4:41982220:T:C | L143P | 0.975 |
| 4:41982186:T:A | W132R | 0.973 |
| 4:41982186:T:C | W132R | 0.973 |
| 4:41982667:G:T | G292V | 0.972 |
| 4:41982796:A:C | D335A | 0.971 |
| 4:41982784:C:A | A331E | 0.970 |
| 4:41982796:A:T | D335V | 0.970 |
| 4:41982797:C:A | D335E | 0.969 |
| 4:41982797:C:G | D335E | 0.969 |
| 4:41982805:C:A | T338K | 0.968 |
dbSNP variants (sampled 300 via entrez): RS1000410786 (4:41981634 T>C), RS1001674645 (4:41981027 C>T), RS1001957709 (4:41981351 A>C), RS1002522322 (4:41986077 C>G), RS1002677299 (4:41979759 G>A), RS1002960824 (4:41980094 T>C), RS1003050761 (4:41986729 G>A,T), RS1003192274 (4:41986340 T>C), RS1003490562 (4:41981652 C>G,T), RS1003810658 (4:41984739 T>C), RS1004308327 (4:41981977 G>A), RS1005162394 (4:41986677 T>A), RS1005257393 (4:41980982 T>G), RS1005521679 (4:41986446 A>C,G), RS1006016732 (4:41986325 G>A)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
4 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005355_3 | Helping behaviour (self reported) | 5.000000e-07 |
| GCST005355_5 | Helping behaviour (self reported) | 3.000000e-06 |
| GCST005839_40 | Depression | 3.000000e-09 |
| GCST009600_120 | Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) | 3.000000e-10 |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
17 total (human), top 17 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Valproic Acid | increases methylation, increases expression | 3 |
| aristolochic acid I | increases expression | 1 |
| triphenyl phosphate | affects expression | 1 |
| trichostatin A | increases expression | 1 |
| S-(1,2-dichlorovinyl)cysteine | affects cotreatment, increases expression | 1 |
| licochalcone B | increases expression | 1 |
| theaflavin-3,3’-digallate | affects expression | 1 |
| Acetaminophen | decreases expression | 1 |
| Demecolcine | increases expression | 1 |
| Lipopolysaccharides | affects cotreatment, increases expression | 1 |
| Niclosamide | decreases expression | 1 |
| Potassium Chloride | decreases response to substance, increases expression | 1 |
| Dronabinol | decreases response to substance, increases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Aflatoxin B1 | increases methylation | 1 |
| Okadaic Acid | increases expression | 1 |
| Particulate Matter | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.